Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTBK2 Inhibitors

TTBK2 inhibitors are a class of chemical compounds designed to specifically inhibit the function of tau tubulin kinase 2 (TTBK2), a serine/threonine kinase that plays a crucial role in regulating various cellular processes. TTBK2 is involved in phosphorylating proteins, particularly tubulin and tau, which are key components of the microtubule network within cells. This kinase is also associated with important regulatory functions in cilia assembly, intracellular transport, and cytoskeletal dynamics. TTBK2 inhibitors work by binding to the kinase's active site or allosteric regions, blocking its ability to transfer phosphate groups to its substrate proteins. Inhibiting TTBK2 activity can lead to alterations in cellular signaling pathways and affect the structural stability of the cytoskeleton.

Chemically, TTBK2 inhibitors are typically small molecules with structural features that allow them to fit precisely within the ATP-binding pocket or other critical regions of the enzyme. These inhibitors are often designed to mimic the natural substrates or ATP itself, competing for binding and effectively reducing kinase activity. Specificity is a key factor in the design of TTBK2 inhibitors, as TTBK2 shares structural similarities with other kinases in the serine/threonine kinase family. Thus, researchers focus on developing inhibitors that target unique regions of the TTBK2 protein to minimize cross-reactivity with other kinases. Studying these inhibitors helps to elucidate the precise role of TTBK2 in cellular processes, particularly in microtubule organization and phosphorylation events, providing insights into the broader mechanisms of kinase regulation and cytoskeletal maintenance.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$67.00
$306.00
2
(1)

A cyclin-dependent kinase inhibitor that may also inhibit TTBK2 by targeting its kinase domain, potentially affecting tau phosphorylation.

Indirubin-3′-monoxime

160807-49-8sc-202660
sc-202660A
sc-202660B
1 mg
5 mg
50 mg
$77.00
$315.00
$658.00
1
(1)

Known to inhibit various kinases; its broad activity spectrum suggests potential for indirect inhibition of TTBK2.

Kenpaullone

142273-20-9sc-200643
sc-200643A
sc-200643B
sc-200643C
1 mg
5 mg
10 mg
25 mg
$60.00
$150.00
$226.00
$495.00
1
(1)

Inhibits cyclin-dependent kinases and might affect TTBK2 indirectly due to its role in cell cycle regulation and tau protein phosphorylation.

Harmine

442-51-3sc-202644
sc-202644A
sc-202644B
sc-202644C
sc-202644D
sc-202644E
sc-202644F
250 mg
500 mg
1 g
10 g
50 g
100 g
500 g
$52.00
$102.00
$124.00
$540.00
$1438.00
$2560.00
$11230.00
2
(2)

A dual-specificity tyrosine phosphorylation-regulated kinase inhibitor, which may also affect TTBK2 activity indirectly.

5-Iodotubercidin

24386-93-4sc-3531
sc-3531A
1 mg
5 mg
$150.00
$455.00
20
(2)

An adenosine kinase inhibitor that could indirectly impact TTBK2 signaling pathways through modulation of cellular adenosine levels.

AZD7762

860352-01-8sc-364423
2 mg
$107.00
(1)

A checkpoint kinase inhibitor that potentially impacts pathways related to TTBK2's role in DNA damage response and cell cycle control.

Sunitinib Malate

341031-54-7sc-220177
sc-220177A
sc-220177B
10 mg
100 mg
3 g
$193.00
$510.00
$1072.00
4
(1)

A receptor tyrosine kinase inhibitor that might influence TTBK2 activity indirectly through its broad spectrum of kinase inhibition.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that could affect TTBK2 indirectly by altering downstream signaling pathways involved in cell survival and metabolism.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor potentially affecting signaling pathways that intersect with TTBK2's role in cellular stress responses.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAP kinase inhibitor that might indirectly modulate TTBK2 activity through pathways involved in inflammation and stress response.